nach oben

Erschienen in:

06.12.2017

Understanding the need for assistance with survey completion in people with Huntington disease

verfasst von: Elizabeth A. Hahn, Nancy R. Downing, Julie C. Stout, Jane S. Paulsen, Becky Ready, Siera Goodnight, Jin-Shei Lai, Jennifer A. Miner, Noelle E. Carlozzi

Erschienen in: Quality of Life Research | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In Huntington disease (HD), motor, cognitive, and psychiatric changes can have a detrimental impact on health-related quality of life (HRQOL). The purpose of this paper is to describe the extent and type of assistance needed to complete online HRQOL surveys, and the impact of assistance on HRQOL scores.

Methods

A patient-reported outcome measurement system was developed for HD-specific HRQOL. Individuals across the prodromal and diagnosed disease severity spectrum (n = 532) completed surveys by computer, and reported the amount and type of assistance they received.

Results

Some participants (n = 56; 10.5%) did not complete all surveys; this group had larger proportions with late stage disease, racial/ethnic minority status, low education and single marital status, and poorer motor, independence and cognitive function compared to those who completed all surveys (n = 476). Overall, 72% of individuals did not receive assistance, 11% received computer assistance only, and 17% received assistance answering the survey questions. The majority of late stage individuals (78%) received some assistance compared to early stage (29%) and prodromal individuals (< 1%). Those who received assistance had higher proportions with late stage disease, were older, had less education, and had poorer functional and cognitive skills. Before and after adjustment for sociodemographic and clinical characteristics, those who received assistance had poorer scores on some HRQOL outcomes than those who did not receive assistance.

Conclusions

Computer-based assessments are feasible for many persons with HD, although other methods may also be needed. Clinicians and researchers should develop strategies to assist people with HD to complete HRQOL surveys.

Nance, M. A. (1998). Huntington disease: Clinical, genetic, and social aspects. Journal of Geriatric Psychiatry and Neurology, 11(2), 61–70.CrossRefPubMed

MacDonald, M. E., Ambrose, C. M., Duyao, M. P., Myers, R. H., Lin, C., Srinidhi, L., Barnes, G., Taylor, S. A., James, M., & Groot, N., & Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72(6), 971–983.

Pringsheim, T., Wiltshire, K., Day, L., Dykeman, J., Steeves, T., & Jette, N. (2012). The incidence and prevalence of Huntington’s disease: A systematic review and meta-analysis. Movement Disorders, 27(9), 1083–1091.CrossRefPubMed

Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., Scahill, R. I., Leavitt, B. R., Stout, J. C., & Paulsen, J. S. (2014). Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10, 204–216.CrossRefPubMed

Paulsen, J. S. (2010). Early detection of Huntington’s disease. Future Neurology, 5(1), 85–104.CrossRef

Ross, C. A., Becher, M. W., Colomer, V., Engelender, S., Wood, J. D., & Sham, A. H. (1997). Huntington’s disease and dentatorubral-pallidoluysian atrophy: Proteins, pathogenesis and pathology. Brain Pathology, 7(3), 1003–1016.CrossRefPubMed

Carlozzi, N. E., & Tulsky, D. S. (2013). Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. Journal of Health Psychology, 18(2), 212–225.CrossRefPubMed

Carlozzi, N. E., Schilling, S. G., Lai, J. S., Paulsen, J. S., Hahn, E. A., Perlmutter, J. S., Ross, C. A., Downing, N. R., Kratz, A. L., McCormack, M. K., Nance, M. A., Quaid, K. A., Stout, J. C., Gershon, R. C., Ready, R. E., Miner, J. A., Barton, S. K., Perlman, S. L., Rao, S. M., Frank, S., Shoulson, I., Marin, H., Geschwind, M. D., Dayalu, P., Goodnight, S. M., & Cella, D. (2016). HDQLIFE: Development and assessment of health-related quality of life in Huntington disease (HD). Quality of Life Research, 25(10), 2441–2455.CrossRefPubMed

DeWalt, D. A., Rothrock, N., Yount, S., & Stone, A. A., & PROMIS Cooperative Group. (2007). Evaluation of item candidates: The PROMIS qualitative item review. Medical Care, 45(5 Suppl 1), S12–S21.CrossRefPubMedPubMedCentral

10.

Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., Cook, K., Devellis, R., Dewalt, D., Fries, J. F., Gershon, R., Hahn, E. A., Pilkonis, P., Revicki, D., Rose, M., Weinfurt, K., Hays, R., & Lai, J. S., & PROMIS Cooperative Group. (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. Journal of Clinical Epidemiology, 63(11), 1179–1194.CrossRefPubMedPubMedCentral

11.

Cella, D., Nowinski, C., Peterman, A., Victorson, D., Miller, D., Lai, J.-S., & Moy, C. (2011). The Neurology Quality-of-Life Measurement Initiative. Archives of Physical Medicine and Rehabilitation, 92(10 Suppl), S28–S36.CrossRefPubMedPubMedCentral

12.

Gershon, R., Lai, J., Bode, R., Choi, S., Moy, C., Bleck, T., Miller, D., Peterman, A., & Cella, D. (2012). Neuro-QOL: Quality of life item banks for adults with neurological disorders: Item development and calibrations based upon clinical and general population testing. Quality of Life Research, 21(3), 475–486.CrossRefPubMed

13.

van der Linden, W. J., & Hambleton, R. K. (1997). Handbook of modern item response theory. New York: Springer.CrossRef

14.

Cella, D., Gershon, R., Lai, J.-S., & Choi, S. (2007). The future of outcomes measurement: Item banking, tailored short-forms, and computerized adaptive assessment. Quality of Life Research, 16(Suppl 1), 133–141.CrossRefPubMed

15.

Carlozzi, N. E., Downing, N. R., McCormack, M. K., Schilling, S. G., Perlmutter, J. S., Hahn, E. A., Lai, J. S., Frank, S., Quaid, K. A., Paulsen, J. S., Cella, D., Goodnight, S. M., Miner, J. A., & Nance, M. A. (2016). New measures to capture end of life concerns in Huntington disease: Meaning and purpose and concern with death and dying from HDQLIFE (a patient-reported outcomes measurement system). Quality of Life Research, 25(10), 2403–2415.CrossRefPubMedPubMedCentral

16.

Carlozzi, N. E., Schilling, S. G., Lai, J. S., Perlmutter, J. S., Nance, M. A., Waljee, J. F., Miner, J. A., Barton, S. K., Goodnight, S. M., & Dayalu, P. (2016). HDQLIFE: The development of two new computer adaptive tests for use in Huntington disease, Speech Difficulties, and Swallowing Difficulties. Quality of Life Research, 25(10), 2417–2427.CrossRefPubMedPubMedCentral

17.

Carlozzi, N. E., Downing, N. R., Schilling, S. G., Lai, J. S., Goodnight, S. M., Miner, J. A., & Frank, A., S (2016). The development of a new computer adaptive test to evaluate chorea in Huntington disease: HDQLIFE Chorea. Quality of Life Research, 25(10), 2429–2439.CrossRefPubMedPubMedCentral

18.

Kremer, H. P. H. & Hungtington Study Group. (1996). Unified Huntington’s disease rating scale: Reliability and consistency. Movement Disorders, 11, 136–142.CrossRef

19.

Shoulson, I., & Fahn, S. (1979). Huntington disease clinical care and evaluation. Neurology, 29(1), 1–1.CrossRefPubMed

20.

Marder, K., Zhao, H., Myers, R., Cudkowicz, M., Kayson, E., Kieburtz, K., Orme, C., Paulsen, J., Penney, J., & Siemers, E. (2000). Rate of functional decline in Huntington’s disease. Neurology, 54(2), 452–452.CrossRefPubMed

21.

Smith, A. (1995). Symbol Digit Modalities Test: Manual. Los Angeles, CA: Western Psychological Services.

22.

Stroop, J. R. (1992). Studies of interference in serial verbal reactions (Reprinted from Journal Experimental-Psychology, Vol 18, Pg 643–662, 1935). Journal of Experimental Psychology: General, 121(1), 15.CrossRef

23.

Üstün, T. B., Chatterji, S., Kostanjsek, N., Rehm, J., Kennedy, C., Epping-Jordan, J., Saxena, S., Korff, M. v., & Pull, C. (2010). Developing the World Health Organization Disability Assessment Schedule 2.0. Bulletin of the World Health Organization, 88(11), 815–823.CrossRefPubMedPubMedCentral

24.

IBM Corporation. (2013). IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corporation.

25.

US Food and Drug Administration. (2009). Guidance for industry. Patient-reported outcome measures: Use in medical product development to support labeling claims. Retrieved June 15, 2017, from http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071975.pdf.

26.

Cella, D., Hahn, E. A., Jensen, S. E., Butt, Z., Nowinski, C. J., Rothrock, N., & Lohr, K. N. (2015). Patient-reported outcomes in performance measurement. Publication No. BK-0014–1509. Research Triangle Park, NC: RTI Press.CrossRef

27.

Ho, A. K., Gilbert, A. S., Mason, S. L., Goodman, A. O., & Barker, R. A. (2009). Health-related quality of life in Huntington’s disease: Which factors matter most? Movement Disorders, 24(4), 574–578.CrossRefPubMed

28.

Read, J., Jones, R., Owen, G., Leavitt, B. R., Coleman, A., Roos, R. A. C., Dumas, E. M., Durr, A., Justo, D., & Say, M. (2013). Quality of life in Huntington’s disease: A comparative study investigating the impact for those with pre-manifest and early manifest disease, and their partners. Journal of Huntington’s Disease, 2(2), 159–175.PubMed

29.

Ready, R. E., Mathews, M., Leserman, A., & Paulsen, J. S. (2008). Patient and caregiver quality of life in Huntington’s disease. Movement Disorders, 23(5), 721–726.CrossRefPubMedPubMedCentral

30.

Rutherford, C., Costa, D., Mercieca-Bebber, R., Rice, H., Gabb, L., & King, M. (2016). Mode of administration does not cause bias in patient-reported outcome results: A meta-analysis. Quality of Life Research, 25, 559–574.CrossRefPubMed

31.

Hahn, E. A., & Cella, D. (2003). Health outcomes assessment in vulnerable populations: Measurement challenges and recommendations. Archives of Physical Medicine and Rehabilitation, 84(Suppl 2), S35-S42.

32.

Hahn, E. A., Cella, D., Dobrez, D. G., Shiomoto, G., Taylor, S. G., Galvez, A. G., Diaz, P., Valenzuela, V., Chiang, H. L., Khan, S., Hudgens, S. A., & Du, H. (2003). Quality of life assessment for low literacy Latinos: A new multimedia program for self-administration. Journal of Oncology Management, 12(5), 9–12.PubMed

33.

Hahn, E., Cella, D., Dobrez, D., Shiomoto, G., Marcus, E., Taylor, S. G., Vohra, M., Chang, C. H., Wright, B. D., Linacre, J. M., Weiss, B. D., Valenzuela, V., Chiang, H. L., & Webster, K. (2004). The Talking Touchscreen: A new approach to outcomes assessment in low literacy. Psycho-Oncology, 13(2), 86–95.CrossRefPubMed

34.

Hahn, E., Choi, S., Griffith, J., Yost, K., & Baker, D. (2011). Health literacy assessment using Talking Touchscreen Technology (Health LiTT): A new item response theory-based measure of health literacy. Journal of Health Communication, 16(Supplement 3), 150–162.CrossRefPubMedPubMedCentral

35.

Yost, K. J., Webster, K., Baker, D. B., Jacobs, E. A., Anderson, A., & Hahn, E. A. (2010). Acceptability of the talking touchscreen for health literacy assessment. Journal of Health Communication, 15(Suppl. 2), 80–92.CrossRefPubMedPubMedCentral

36.

Hahn, E. A., Burns, J. L., Jacobs, E. A., Ganschow, P. S., Garcia, S. F., Rutsohn, J. P., & Baker, D. W. (2015). Health literacy and patient-reported outcomes: A cross-sectional study of underserved English- and Spanish-speaking patients with type 2 diabetes. Journal of Health Communication, 20(Supp2), 4–15.CrossRefPubMed

37.

Downing, N. R., Kim, J.-I., Williams, J. K., Long, J. D., Mills, J. A., & Paulsen, J. S. (2014). WHODAS 2.0 in prodromal Huntington disease: Measures of functioning in neuropsychiatric disease. European Journal of Human Genetics, 22(8), 958–963.CrossRefPubMed

38.

Duff, K., Paulsen, J. S., Beglinger, L. J., Langbehn, D. R., Wang, C., Stout, J. C., Ross, C. A., Aylward, E., Carlozzi, N. E., & Queller, S. (2010). “Frontal” behaviors before the diagnosis of Huntington’s disease and their relationship to markers of disease progression: Evidence of early lack of awareness. Journal of Neuropsychiatry and Clinical Neurosciences, 22(2), 196–207.CrossRefPubMedPubMedCentral

39.

Scientific Advisory Committee of the Medical Outcomes Trust, Lohr, K. N., Aaronson, N., Alonso, J., Burnam, A., Patrick, D. L., Perrin, E. B., & Stein, R. (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11(3), 193–205.CrossRef

40.

Groves, R. M. (2009). Survey methodology (2nd ed.). Hoboken, NJ: Wiley.

41.

Morrison, P. J., Harding-Lester, S., & Bradley, A. (2011). Uptake of Huntington disease predictive testing in a complete population. Clinical Genetics, 80(3), 281–286.CrossRefPubMed

42.

Bull, M. T., Darwin, K., Venkataraman, V., Wagner, J., Beck, C. A., Dorsey, E., & Biglan, K. M. (2014). A pilot study of virtual visits in Huntington disease. Journal of Huntington’s Disease, 3(2), 189–195.PubMed

Titel: Understanding the need for assistance with survey completion in people with Huntington disease
verfasst von: Elizabeth A. Hahn
Nancy R. Downing
Julie C. Stout
Jane S. Paulsen
Becky Ready
Siera Goodnight
Jin-Shei Lai
Jennifer A. Miner
Noelle E. Carlozzi
Publikationsdatum: 06.12.2017
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 3/2018
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-017-1747-6

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Quality of life at 6 years after occupational injury

Psychometric evaluation of the PainCAS Interference with Daily Activities, Psychological/Emotional Distress, and Pain scales

The association between somatic and psychological discomfort and health-related quality of life according to the elderly and non-elderly

Establishing clinical severity for PROMIS® measures in adult patients with rheumatic diseases

A (five-)level playing field for mental health conditions?: exploratory analysis of EQ-5D-5L-derived utility values

Lifestyle factors and social ties associated with the frequency of laughter after the Great East Japan Earthquake: Fukushima Health Management Survey